Unbiased Analysis of Today's Healthcare Issues

Archive for the 'Current Events' Category

Friday Links

Health state utilities: Best practices and critique. Health, big data and privacy. Tying drug prices to patient outcomes. Dr. Watson. Absolute vs. relative risk.

Read the rest of this entry »

2016 Nobel Prize in Medicine goes to…

Yoshinori Ohsumi. He won the award for his discoveries of mechanisms for autophagy. What is autophagy? The Nobel Prize website explains: The word autophagy originates from the Greek words auto-, meaning “self”, and phagein, meaning “to eat”. Thus,autophagy denotes “self eating”. This concept emerged during the 1960’s, when researchers first observed that the cell could […]

Read the rest of this entry »

2016 Nobel Prize in Economics goes to…

…Oliver Hart and Bengt Holmström for their research on contract theory. One of my favorite papers in all of economics is Holmstrom and Milgrom’s 1991 paper titled “Multitask Principal-Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design.”  In a world where health care is increasingly moving to value-based payment, payers (i.e., insurance companies, employers, and the government) are increasingly […]

Read the rest of this entry »

Friday Links

The for-profit charity? The reliability of Chinese RCT data. 122. Hackable insulin pumps? Nano cars

Read the rest of this entry »

China fabricates clinical trial data?

Academic integrity is one of the bedrocks upon which research is founded.  With that said, it is with great concern that I came across an article that stated that 80% of Chinese clinical trials data is fabricated.  Science Alert reports: The review looked at data from 1,622 clinical trial programs of new pharmaceutical drugs awaiting regulator approval for mass […]

Read the rest of this entry »

Friday Links

Using biomarker data. Cancer moonshot has started. Frakt on value frameworks. A downside of work. Drug price negotiation coming to the U.S.

Read the rest of this entry »

The Innovation and Value Initiative (IVI) has launched

I’m excited to announce that the Innovation and Value Initiative (IVI) has just launched.  I will be serving as the Director of Research.  Below, I have reposted the IVI press release so you can lear more about the initiative. Precision Health Economics today launched the Innovation and Value Initiative (IVI), a multi-stakeholder scientific initiative to […]

Read the rest of this entry »

Links to Start your Week

Physicians and numeracy. Should pharmaceutical research be not-for-profi? Index funds turn 40. Cancer care: US vs EU Hillary Clinton’s “full medical records”

Read the rest of this entry »

Is Precision Medicine ready for prime time

According to two researchers, the answer is no.  As they write at Stat: As we wrote recently in Science, three key barriers are impeding the drive toward truly transformational precision medicine: researchers often don’t rigorously test the biological theories that supposedly explain why a targeted treatment should work; they haven’t fully determined the accuracy of the diagnostic […]

Read the rest of this entry »

Links

SF is the new Detroit? Is customer satisfaction liked to patient care or advertising? Trust genetic or traditional medical tests? Are ACOs starting to save money? Max Ritvo, RIP

Read the rest of this entry »